
The MRC Laboratory of Molecular Biology and AstraZeneca are today announcing a plan for a research fund to facilitate collaboration between LMB and AstraZeneca and MedImmune. The fund will support a range of pre-clinical research projects aimed at better understanding fundamental biology and disease.